ViiV Healthcare presented results today at this week’s CROI conference from its EMBRACE study demonstrating

March 12, 2025 No Comments

At CROI 2025, Georg Behrens, MD, PhD, professor for T-Cell Immunology at Hannover Medical School,

March 12, 2025 No Comments

Investigators found they could reduce the once-daily (OD) dosing of theantiretroviral therapy (ART) bictegravir/emtricitabine/tenofovir alafenamide

March 11, 2025 No Comments

At the CROI 2025, Moupali Das, MD, MPH, vice president of HIV prevention and virology

March 11, 2025 No Comments

Beatriz Mothe, MD, PhD, an infectious disease specialist at the IrsiCaixa AIDS Research Institute and

March 11, 2025 No Comments

Federal clinical research funding freezes being carried out by the Trump Administration is affecting the

March 11, 2025 No Comments

At CROI 2025, Kellie Hawkins, MD, assistant professor of medicine at the University of Colorado

March 11, 2025 No Comments

At CROI 2025, we spoke with three researchers from Université de Montréal about the role

March 10, 2025 No Comments

Tuberculosis lives and thrives in the lungs. When the bacteria that cause the disease are

March 10, 2025 No Comments

Herpes simplex virus-1 (HSV-1) is commonly known for causing blisters and sores. But in some

March 10, 2025 No Comments

Schedule an Appointment

Quick Links